Origen de la red de primer grado John Donovan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY.
5
| Private Company | Pharmaceuticals: Major | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a John Donovan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| New York University | College/University | Undergraduate Degree | |
| Adelphi University | College/University | Undergraduate Degree | |
| University of Catania | College/University | Doctorate Degree | |
| University of California | College/University | Corporate Officer/Principal | |
| KINTARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| Theia Therapeutics, Inc. | Founder | ||
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 9 |
| Italia | 2 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 4 |
| Finance | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 2 |
| Director/Board Member | 2 |
| President | 1 |
| Chief Executive Officer | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Napoleone Ferrara | 8 |
| Joni Foley | 3 |
| Andrew Finamore | 1 |
| Michael Finamore | 1 |
| Emma Ebere | 1 |
- Bolsa de valores
- Insiders
- John Donovan
- Conexiones Empresas
